Bond Bayris 4.625% ( USU07265AG34 ) in USD
Issuer | Bayris |
Market price | ![]() |
Country | ![]() |
ISIN code |
![]() |
Interest rate | 4.625% per year ( payment 2 times a year) |
Maturity | 24/06/2038 |
Prospectus brochure in PDF format is unavailable at this time We will provide it as soon as possible |
|
Minimal amount | 200 000 USD |
Total amount | 1 000 000 000 USD |
Cusip | U07265AG3 |
Standard & Poor's ( S&P ) rating | BBB ( Lower medium grade - Investment-grade ) |
Moody's rating | Baa1 ( Lower medium grade - Investment-grade ) |
Next Coupon | 25/12/2025 ( In 101 days ) |
Detailed description |
Bayer is a multinational pharmaceutical and life science company with core businesses in pharmaceuticals, consumer health, and agricultural products. This informative financial article focuses on a bond issuance, identified by ISIN USU07265AG34 and CUSIP U07265AG3, originating from Germany, where the esteemed issuer is Bayer, a globally significant German multinational pharmaceutical and life sciences company, headquartered in Leverkusen, known for its extensive operations spanning human and veterinary pharmaceuticals, consumer health, and agricultural sciences, whose diversified portfolio contributes to its robust market position; this particular bond, denominated in USD, is currently valued at 100% of its face value, offers a fixed annual interest rate of 4.625% with semi-annual payments, represents a total issue size of 1,000,000,000, stipulates a minimum investment lot of 200,000, matures on June 24, 2038, and is rated BBB by Standard & Poor's and Baa1 by Moody's. |